Literature DB >> 16482635

A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice.

Yuan-Xiang Zhou1, Maggie Yuk-Ting Lee, James Ming-Him Ng, Mee-Len Chye, Wing-Kin Yip, Sze-Yong Zee, Eric Lam.   

Abstract

AIM: To cost-effectively express the 23-ku pE2, the most promising subunit vaccine encoded by the E2 fragment comprising of the 3'-portion of hepatitis E virus (HEV) open reading frame 2 (ORF2) in plastids of tobacco (Nicotiana tabacum cv. SR1), to investigate the transgene expression and pE2 accumulation in plastids, and to evaluate the antigenic effect of the plastid-derived pE2 in mice.
METHODS: Plastid-targeting vector pRB94-E2 containing the E2 fragment driven by rice psbA promoter was constructed. Upon delivery into tobacco plastids, this construct could initiate homologous recombination in psaB-trnfM and trnG-psbC fragments in plastid genome, and result in transgene inserted between the two fragments. The pRB94-E2 was delivered with a biolistic particle bombardment method, and the plastid-transformed plants were obtained following the regeneration of the bombarded leaf tissues on a spectinomycin-supplemented medium. Transplastomic status of the regenerated plants was confirmed by PCR and Southern blot analysis, transgene expression was investigated by Northern blot analysis, and accumulation of pE2 was measured by ELISA. Furthermore, protein extracts were used to immunize mice, and the presence of the pE2-reactive antibodies in serum samples of the immunized mice was studied by ELISA.
RESULTS: Transplastomic lines confirmed by PCR and Southern blot analysis could actively transcribe the E2 mRNA. The pE2 polypeptide was accumulated to a level as high as 13.27 microg/g fresh leaves. The pE2 could stimulate the immunized mice to generate pE2-specific antibodies.
CONCLUSION: HEV-E2 fragment can be inserted into the plastid genome and the recombinant pE2 antigen derived is antigenic in mice. Hence, plastids may be a novel source for cost-effective production of HEV vaccines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482635      PMCID: PMC4066044          DOI: 10.3748/wjg.v12.i2.306

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  High-yield production of a human therapeutic protein in tobacco chloroplasts.

Authors:  J M Staub; B Garcia; J Graves; P T Hajdukiewicz; P Hunter; N Nehra; V Paradkar; M Schlittler; J A Carroll; L Spatola; D Ward; G Ye; D A Russell
Journal:  Nat Biotechnol       Date:  2000-03       Impact factor: 54.908

2.  [Headache, high fever and cognition disorder: tuberculous meningoencephalitis].

Authors:  S Kawasaki; T Ideta; T Okajima; H Tokuomi; S Suko
Journal:  Nihon Rinsho       Date:  1975-04-10

3.  The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton.

Authors:  M Zafrullah; M H Ozdener; S K Panda; S Jameel
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus.

Authors:  Yi-Hua Zhou; Robert H Purcell; Suzanne U Emerson
Journal:  Vaccine       Date:  2005-05-02       Impact factor: 3.641

5.  Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells.

Authors:  M Zhang; S U Emerson; H Nguyen; R E Engle; S Govindarajan; J L Gerin; R H Purcell
Journal:  Vaccine       Date:  2001-12-12       Impact factor: 3.641

6.  A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus.

Authors:  S W Im; J Z Zhang; H Zhuang; X Y Che; W F Zhu; G M Xu; K Li; N S Xia; M H Ng
Journal:  Vaccine       Date:  2001-06-14       Impact factor: 3.641

7.  Overview of Hepatitis E Virus.

Authors:  Susan Skidmore
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

Review 8.  Hepatitis E virus.

Authors:  Suzanne U Emerson; Robert H Purcell
Journal:  Rev Med Virol       Date:  2003 May-Jun       Impact factor: 6.989

9.  Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome.

Authors:  A W Tam; M M Smith; M E Guerra; C C Huang; D W Bradley; K E Fry; G R Reyes
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

10.  Expression of the B subunit of E. coli heat-labile enterotoxin in the chloroplasts of plants and its characterization.

Authors:  Tae-Jin Kang; Nguyen-Hoang Loc; Mi-Ok Jang; Yong-Suk Jang; Young-Sook Kim; Jo-Eun Seo; Moon-Sik Yang
Journal:  Transgenic Res       Date:  2003-12       Impact factor: 2.788

View more
  13 in total

Review 1.  Diagnosis of hepatitis E.

Authors:  Rakesh Aggarwal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-10-02       Impact factor: 46.802

2.  Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery.

Authors:  Abdoreza Davoodi-Semiromi; Melissa Schreiber; Samson Nalapalli; Dheeraj Verma; Nameirakpam D Singh; Robert K Banks; Debopam Chakrabarti; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2009-12-28       Impact factor: 9.803

Review 3.  The green vaccine: A global strategy to combat infectious and autoimmune diseases.

Authors:  Abdoreza Davoodi-Semiromi; Nalapalli Samson; Henry Daniell
Journal:  Hum Vaccin       Date:  2009-07-23

4.  Codon-Optimized Expression and Purification of Truncated ORF2 Protein of Hepatitis E Virus in Escherichia coli.

Authors:  Fatemeh Farshadpour; Reza Taherkhani; Manoochehr Makvandi; Hamid Rajabi Memari; Ali Reza Samarbafzadeh
Journal:  Jundishapur J Microbiol       Date:  2014-07-01       Impact factor: 0.747

Review 5.  Chloroplast genomes: diversity, evolution, and applications in genetic engineering.

Authors:  Henry Daniell; Choun-Sea Lin; Ming Yu; Wan-Jung Chang
Journal:  Genome Biol       Date:  2016-06-23       Impact factor: 13.583

Review 6.  Plant Platforms for Efficient Heterologous Protein Production.

Authors:  Siddhesh B Ghag; Vinayak S Adki; Thumballi R Ganapathi; Vishwas A Bapat
Journal:  Biotechnol Bioprocess Eng       Date:  2021-08-07       Impact factor: 2.836

Review 7.  Plant-made vaccine antigens and biopharmaceuticals.

Authors:  Henry Daniell; Nameirakpam D Singh; Hugh Mason; Stephen J Streatfield
Journal:  Trends Plant Sci       Date:  2009-10-14       Impact factor: 18.313

8.  Brassica juncea chitinase BjCHI1 inhibits growth of fungal phytopathogens and agglutinates Gram-negative bacteria.

Authors:  Yuanfang Guan; Sathishkumar Ramalingam; Dinesh Nagegowda; Paul W J Taylor; Mee-Len Chye
Journal:  J Exp Bot       Date:  2008-07-31       Impact factor: 6.992

9.  Development of enzyme-linked immunosorbent assays using 2 truncated ORF2 proteins for detection of IgG antibodies against hepatitis E virus.

Authors:  Reza Taherkhani; Manoochehr Makvandi; Fatemeh Farshadpour
Journal:  Ann Lab Med       Date:  2014-02-13       Impact factor: 3.464

Review 10.  Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.

Authors:  Milena Mazalovska; J Calvin Kouokam
Journal:  Viruses       Date:  2020-07-30       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.